Dr. Neelam Taneja


e-Mail: drneelampgi@yahoo.com

Degrees and Qualifications :

MBBS, MD (Microbiology) FIMSA, Dip Vaccinology

Current Affiliations :


Areas of Interest :

Epidemiology, diagnosis, outbreak investigation and antimicrobial resistance  of food borne and zoonotic enteropathogens  and uropathogens, hospital acquired infections, immune responses and vaccine development for Shigella and finding novel drug targets against multi drug resistant bacteria.


Ten Best Publications :

Best Publications:
1.    Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial. PK Sharma, TP Yadav, RK Gautam, N Taneja, L Satyanarayana. Journal of the American Academy of Dermatology 2000; 42 (2), 241-244. (Cited- 150 times) 

2.    Occurrence of ESBL & Amp-C [beta]-lactamases & susceptibility to newer antimicrobial agents in complicated UTI. N Taneja, P Rao, J Arora, A Dogra. Indian Journal of Medical Research 2008; 127 (1), 85. (Cited- 116 times)

3.    Pediatric urinary tract infections in a tertiary care center from north India.N Taneja, SS Chatterjee, M Singh, S Singh, M Sharma. Indian J Med Res 2010; 131, 101-105.  (Cited- 80 times)

4.    A prospective study of hospital-acquired infections in burn patients at a tertiary care referral centre in North India. N Taneja, R Emmanuel, PS Chari, M Sharma. Burns, 2004; 30 (7), 665-669. (Cited- 79 times)

5.    Molecular characterization of multidrug-resistant Shigella species isolated from epidemic and endemic cases of shigellosis in India. GP Pazhani, SK Niyogi, AK Singh, B Sen, N Taneja, M Kundu. Journal of medical microbiology 2008; 57 (7), 856-863. (Cited- 72 times)

6.    Imipenem resistance in nonfermenters causing nosocomial urinary tract infections. N Taneja, S Maharwal, M Sharma. Indian journal of medical sciences 2003; 57 (7), 294. (Cited- 69 times)

7.    Changing epidemiology of shigellosis and emergence of ciprofloxacin-resistant Shigellae in India. N Taneja. Journal of clinical microbiology 2007; 45 (2), 678-679. (Cited- 64 times)

8.    Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India. N Taneja, G Singh, M Singh, M Sharma. The Indian journal of medical research 2011,133 (6), 681. (Cited -58 times)

9.    Significance of vancomycin resistant enterococci from urinary specimens at a tertiary care centre in northern India. N Taneja, P Rani, R Emmanuel, M Sharma. Indian Journal of Medical Research 2004,119 (2), 72. (cited – 50 times)

10.    Outbreaks caused by new variants of Vibrio cholerae O1 El Tor, India. Taneja N, Mishra A, Sangar G, Singh G, Sharma M. Emerg Infect Dis. 2009 Feb;15(2):352-4.
11.    Spread of cholera with newer clones of Vibrio cholerae O1 El Tor, serotype Inaba, in India. B Dutta, R Ghosh, NC Sharma, GP Pazhani, N Taneja, A Raychowdhuri. Journal of clinical microbiology. 2006.44 (9), 3391-3393 (Cited- 35 times)

12.    Taneja N, Mewara A, Kumar A, Verma G, Sharma M. Cephalosporin-resistant Shigella flexneri over 9 years (2001-09) in India. J Antimicrob Chemother. 2012 Mar 12. (Cited- 34 times)

13.    Environmental and epidemiological surveillance of Vibrio cholerae in a cholera‐endemic region in India with freshwater environs. A Mishra, N Taneja, M Sharma. Journal of applied microbiology.2012, 112 (1), 225-237 (Cited – 19 times)

14.    Nosocomial outbreak of diarrhoea by enterotoxigenic Escherichia coli among preterm neonates in a tertiary care hospital in India: pitfalls in healthcare. N Taneja, A Das, DSVR Rao, N Jain, M Singh, M Sharma. Journal of Hospital Infection: 2003, 53 (3), 193-197. (Cited- 18 times)

15.    Viability kinetics, induction, resuscitation and quantitative real‐time polymerase chain reaction analyses of viable but nonculturable Vibrio cholerae O1 in freshwater microcosm. A Mishra, N Taneja, M Sharma. Journal of applied microbiology: 2012, 112 (5), 945-953. (Cited-17 times)

16.    Study of nosocomial urinary tract infections in a pediatric intensive care unit. SM Brindha, M Jayashree, S Singhi, N Taneja. Journal of tropical pediatrics: 2010, 104. (Cited- 15 times)

17.    Epidemiology and molecular characterization of vancomycin resistant Enterococci isolates in India. BY Khudaier, R Tewari, S Shafiani, M Sharma, R Emmanuel, M Sharma. Scandinavian journal of infectious diseases: 2007, 39 (8), 662-670. (Cited- 14 times)

18.    Detection of Shiga toxin variants among Shiga toxin–forming Escherichia coli isolates from animal stool, meat and human stool samples in India. A Kumar, N Taneja, Y Kumar, M Sharma. Journal of applied microbiology 113 (5), 1208-1216 (Cited- 13 times)

19.    Dipstick test for rapid diagnosis of Shigella dysenteriae 1 in bacterial cultures and its potential use on stool samples. N Taneja, F Nato, S Dartevelle, JM Sire, B Garin, LNT Phuong, JC Shako. PloS one: 2011 6 (10), e24830. (Cited- 9 times)

20.    Hydrogen peroxide fogging in an overcrowded tertiary care referral centre: some practical queries. N Taneja, M Biswal, R Emmanuel, M Singh, M Sharma. Journal of Hospital Infection: 2005 60 (1), 85. (Cited- 7 times)

21.    Point prevalence surveys of healthcare-associated infections and use of indwelling devices and antimicrobials over three years in a tertiary care hospital in India. A Kumar, M Biswal, N Dhaliwal, R Mahesh, SB Appannanavar, V Gautam, N Taneja. Journal of Hospital Infection 86 (4), 272-274 (Cited- 6 times)

22.    Amplified fragment length polymorphism of clinical and environmental Vibrio cholerae from a freshwater environment in a cholera-endemic area, India. A Mishra, N Taneja, RK Sharma, R Kumar, NC Sharma, M Sharma. BMC infectious diseases 11 (1), 1    (Cited- 4 times)

23.    Taneja N, Kaur H. Insights into Newer Antimicrobial Agents against Gram-negative Bacteria. Microbiol Insights. 2016 Mar 20; 9: 9-19. (Cited- 4 times)

24.    Serotype profile and molecular characterization of antimicrobial resistance in non-typhoidal Salmonella isolated from gastroenteritis cases over nine years. Neelam Taneja,  Suma B. Appannanavar,  Ajay Kumar,  Garima Varma,  Yashwant Kumar,  Balvinder Mohan, Meera Sharma. Med Microbiol. 2014 Jan; 63(Pt 1):66-73.

25.    An Epidemiological and Environmental Study of Shiga Toxin–Producing Escherichia coli in India. A Kumar, N Taneja, M Sharma. Foodborne pathogens and disease:2014,11 (6), 439-446 (Cited- 2 times)

26.    Molecular characterization of Shiga-toxigenic Escherichia coli isolated from diverse sources from India by multi-locus variable number tandem repeat analysis (MLVA). A Kumar, N Taneja, RK Sharma, H Sharma, T Ramamurthy, M Sharma. Epidemiology and infection:2014,142 (12), 2572-2582 (Cited- 1 time)

27.    Novel Immunogenic Antigens of Shigella. N Taneja, S Pahil, M Sharma. US Patent App. 2013,14/443,555.

28.    Malvi S, Appannanavar S, Mohan B, Kaur H, Gautam N, Bharti B, Kumar Y, Taneja N. Comparative analysis of virulence determinants, antibiotic susceptibility pattern and serogrouping of atypical enteropathogenic E coli versus typical enteropathogenic E.coli in India. J Med Microbiol. 2015; 64(10):1208-15.

29.    Taneja N, Sethuraman N, Mishra A, Mohan B. The 2002 Chandigarh cholera outbreak revisited: utility of MALDI-TOF as a molecular epidemiology tool. Lett Appl Microbiol. 2016 Jun; 62(6):452-8.

Research Grants :

•    Animal challenge study of novel Shigella vaccine antigens common to multiple serotypes 2016 onwards DST
•    A study of serotypic differences in innate and adaptive immune responses in shigellosis in human. 2013-16 (ICMR)
•    Colonization factor analysis and molecular epidemiology of Enterotoxigenic E. coli (ICMR)
•    Integrated Surveillance of Antimicrobial Resistance (AGISAR) for foodborne pathogens Indo-US (WHO). 
•    Strengthening district public health laboratories for laboratory surveillance of communicable diseases of outbreak potential, Phase 1 (2008-09) , phase 2 (2011)WHO APW 
•    Laboratory training of microbiologists of district public health laboratories communicable diseases of outbreak potential. WHO DFC project
•    Finding a common immunodominant target by Reverse vaccinology -ICMR fellow  grant
•    A study of molecular epidemiology and drug resistance mechanisms in ciprofloxacin resistant shigellae (2009-12) ICMR
•    Prevalence, characterization and epidemiological typing of Shiga toxin producing Escherichia coli isolated from meat products, unpasteurised milk, cattle and children in north India. (2008-11)ICMR
•    Molecular epidemiology of V. cholerae causing the recent outbreaks in and around Chandigarh. (2006-09) ICMR
•    Development of a multiplex PCR assay to detect V cholerae from the environment (2007-08). DST Chandigarh
•    Detection of diarrhoeagenic E. coli in aquatic environments in and around Chandigarh by a multiplex PCR assay.(2008-09) DST Chandigarh Project
•    National network on antimicrobial resistance on Enterobacteriaceae (sanctioned 2012) ICMR 
•    Determination of prevalence of carriage of multidrug resistant organisms in healthcare workers of Chandigarh. 2011. DST Chandigarh.
•    Evaluation of MALDI-TOF MS in direct identification of UTI pathogens from urine samples. 2014-15
•    A prospective study of hospital water supply contamination with Legionella spp., Mycobacteria spp. and other potentially pathogenic bacteria in critical areas of PGI 2014-15


Additional Information :

•    WHO advisor for AGISAR project on antimicrobial resistance in food borne pathogens
•    National trainer for Microbiologists under the IDSP (Integrated Disease surveillance Programme)

•    International patent for Novel immunogenic antigens common to Shigella   with patent no - INPCT/IN2013/000703 dated 2013-11-19. 
•    Awarded various international honors including a many research awards, ASM CME award for antimicrobial resistance, WHO fellowship, a Pasteur Institute fellowship, International        Development award for young woman scientist conferred by International society of infectious Diseases and several international travel awards including five from NIH, Wellcome          trust and ESCMID fellowship. 
•    Published 138 peer-reviewed articles in esteemed journals such as Emerging Infectious Diseases and Journal of Antimicrobial Agents and Chemotherapy, Journal of Clinical microbiology. And Journal of Medical Microbiology etc   
•    Elected fellow of International Medical Sciences Academy in recognition of outstanding contribution to advancement of medical sciences in 2009.